Phase 3 Oligodendroglioma Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
GliomaAstrocytoma, IDH-Mutant, Grade 2Astrocytoma, Grade IV+5 more
Nuvation Bio Inc.365 enrolled45 locationsNCT05303519
Recruiting
Phase 3
A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).
Oligodendroglioma
University Hospital Heidelberg406 enrolled19 locationsNCT05331521
Recruiting
Phase 3
A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery
OligodendrogliomaLow-grade Oligodendroglioma1p19q Codeletion
Hospices Civils de Lyon280 enrolled26 locationsNCT04702581
Recruiting
Phase 3
Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma
OligodendrogliomaAstrocytomaOligodendroastrocytoma
Sun Yat-sen University290 enrolled1 locationNCT01649830